Copyright
©The Author(s) 2017.
World J Cardiol. Aug 26, 2017; 9(8): 685-692
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.685
Published online Aug 26, 2017. doi: 10.4330/wjc.v9.i8.685
Table 3 Weight loss and creatinine change per day of treatment in the impasse subgroup (n = 15)
| Variable | mean ± SD | 95%CI | P value |
| Weight loss (kg/d) | |||
| Standard treatment | 0.25 ± 0.64 | (-0.04, 0.58) | |
| Experimental treatment | -1.20 ± 1.30 | (-1.89, -0.57) | |
| Standard-experimental difference | 1.45 ± 1.65 | (0.54, 2.36) | 0.0026 |
| Change in creatinine (μmol/L per day) | |||
| Standard treatment | 7.33 ± 8.65 | (3.01, 11.70) | |
| Experimental treatment | -3.79 ± 11.34 | (-10.41, 1.63) | |
| Standard-experimental difference | 11.13 ± 13.29 | (3.77, 18.49) | 0.008 |
- Citation: Lafrenière G, Béliveau P, Bégin JY, Simonyan D, Côté S, Gaudreault V, Israeli Z, Lavi S, Bagur R. Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure. World J Cardiol 2017; 9(8): 685-692
- URL: https://www.wjgnet.com/1949-8462/full/v9/i8/685.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i8.685